Passage Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Passage Bio, Inc. (PASG) will participate in investor conferences like TD Cowen 44th Annual Health Care Conference and Leerink Partners Global Biopharma Conference to discuss their clinical-stage genetic medicines for neurodegenerative diseases. A webcast will be available for investors on the company's website.

PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will participate in the following upcoming investor conferences:

TD Cowen 44th Annual Health Care Conference
Format: Management will participate in a panel and investor meetings
Date: Tuesday, March 5, 2024
Time: 10:30 a.m. ET
Location: Boston, MA

Leerink Partners Global Biopharma Conference
Format: Management will participate in investor meetings
Date: Wednesday, March 13, 2024
Location: Miami, FL

A live webcast of the panel discussion will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the panel will be available for 30 days following the event.

About Passage Bio

Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. Passage Bio’s lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression.

To learn more about Passage Bio and our steadfast commitment to protecting patients and families against loss in neurodegenerative conditions, please visit: www.passagebio.com.

For further information, please contact:

Investors:
Stuart Henderson
Passage Bio
267.866.0114
shenderson@passagebio.com

Passage Bio Media:
Mike Beyer
Sam Brown Inc. Healthcare Communications
312.961.2502
mikebeyer@sambrown.com

FAQ

When will Passage Bio participate in the TD Cowen 44th Annual Health Care Conference?

Passage Bio will participate in the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 10:30 a.m. ET in Boston, MA.

Where will Passage Bio participate in the Leerink Partners Global Biopharma Conference?

Passage Bio will participate in the Leerink Partners Global Biopharma Conference in Miami, FL for investor meetings on Wednesday, March 13, 2024.

Will there be a webcast available for investors?

Yes, a live webcast of the panel discussion will be available on Passage Bio's website at investors.passagebio.com, with a replay available for 30 days after the event.